Journal of Breast Imaging
Verified
Journal
Journal of Breast Imaging, the official journal of the Society of Breast Imaging, is a peer-reviewed publication that aims to provide high quality, evidence-based content for the global breast imaging medical community. This journal seeks to advance the field of breast imaging, with particular focus on improving patient care and outcomes.
JBI will publish original research, as well as reviews of important scientific, educational and clinical topics. Among the topics covered are screening for breast cancer, diagnosis of disease, image-guided breast procedures, and imaging management of patients with breast cancer. The journal will review emerging and controversial topics by experts to summarize evidence based research and practice while updating readers on practice management topics. JBI will maintain a strong clinical focus with broad appeal with the goal of advancing the field of breast imaging. Source
Actions
Media Outlet details
| Scope | International, Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
| Accepts contributed content | Yes |
Recent Articles
Search ArticlesIssues | Journal of Breast Imaging | Oxford Academic
For full access to this pdf, sign in to an existing account, or purchase an annual subscription. This PDF is available to Subscribers Only As a benefit of your subscription, you can share temporary access to restricted articles. Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period. Please sign in to your personal account to gift article access.
Cystic Breast Disease: What to Do When It’s Not So Cystic
Cystic breast masses are a common entity encountered by breast radiologists. The imaging features of benign and malignant cystic masses may overlap, causing confusion and miscategorization with the potential to produce diagnostic delay and harm. This article provides a review of key differentiating imaging features that help guide appropriate mass characterization and treatment. © Society of Breast Imaging 2025. All rights reserved.
Invasive Lobular Carcinoma in the Screening Setting
Invasive lobular carcinoma (ILC) is the second-most common histologic subtype of breast cancer, constituting 5% to 15% of all breast cancers. It is characterized by an infiltrating growth pattern that may decrease detectability on mammography and US. The use of digital breast tomosynthesis (DBT) improves conspicuity of ILC, and sensitivity is 80% to 88% for ILC.
External Validation of a Commercial Artificial Intelligence Algorithm on a Diverse Population for Detection of False Negative Breast Cancers
Population-level mammographic screening for breast cancer reproducibly decreases the rate of cancer-related deaths in the United States.1 As with any cancer screening program, false negative cancers, which represent malignancies detected between routine screening examinations, remain a challenge.
Potential Impact of an Artificial Intelligence-based Mammography Triage Algorithm on Performance and Workload in a Population-based Screening Sample
To evaluate potential screening mammography performance and workload impact using a commercial artificial intelligence (AI)–based triage device in a population-based screening sample. In this retrospective study, a sample of 2129 women who underwent screening mammograms were evaluated. The performance of a commercial AI-based triage device was compared with radiologists’ reports, actual outcomes, and national benchmarks using commonly used mammography metrics.
Idiopathic Granulomatous Mastitis: Imaging Findings and Outcomes with Nonsteroidal Treatment in a Predominantly Hispanic Population
We describe the demographics, clinical presentation, imaging findings, and treatment response among 235 cases of biopsy-proven idiopathic granulomatous mastitis (IGM) at a single institution. An institutional review board–approved retrospective search of the breast imaging database was performed to select patients with biopsy-proven IGM between 2017 and 2022.
USPSTF Recommendations and Overdiagnosis
Overdiagnosis is the concept that some cancers detected at screening would never have become clinically apparent during a woman’s lifetime in the absence of screening. This could occur if a woman dies of a cause other than breast cancer in the interval between mammographic detection and clinical detection (obligate overdiagnosis) or if a mammographically detected breast cancer fails to progress to clinical presentation. Overdiagnosis cannot be measured directly.
USPSTF Recommendations and Overdiagnosis
Mammography screening benefits women by decreasing breast cancer mortality by 40% to 50% (1–6). Other benefits for screened women include less extensive surgery, less chemotherapy, and removal of high-risk lesions, decreasing subsequent invasive breast cancers (7–15). There are also risks to screening, such as recalls from the screening examination, recommendations for a breast biopsy (most of which can be done with minimally invasive technique), anxiety, and overdiagnosis.
Tips for Addressing Screening Concerns: “Harms of Screening”
Early detection decreases deaths from breast cancer. Yet, there are conflicting recommendations about screening mammography by major professional medical organizations, including the age and frequency with which women should be screened. The controversy over breast cancer screening is centered on 3 main points: the impact on mortality, overdiagnosis, and false positive results. Some studies claim that adverse psychological effects such as anxiety or distress are caused by screening mammography.
Issues | Journal of Breast Imaging | Oxford Academic
This PDF is available to Subscribers Only For full access to this pdf, sign in to an existing account, or purchase an annual subscription.